Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/37357
Title: | Treatment of severe recalcitrant pyoderma gangrenosum with ustekinumab. | Authors: | Mar A. ;Low Z.M. | Institution: | (Low, Mar) Department of Dermatology, Monash Health, Clayton, VIC, Australia | Issue Date: | 11-Jun-2018 | Copyright year: | 2018 | Publisher: | Blackwell Publishing | Place of publication: | Australia | Publication information: | Australasian Journal of Dermatology. 59 (2) (pp 131-134), 2018. Date of Publication: May 2018. | Journal: | Australasian Journal of Dermatology | Abstract: | An increased expression of interleukin-23 has been observed in patients with pyoderma gangrenosum, leading to the use of ustekinumab as a therapeutic option. We report the successful use of ustekinumab in three patients with treatment-resistant pyoderma gangrenosum of varying clinical presentations.Copyright © 2017 The Australasian College of Dermatologists | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/ajd.12744 | ORCID: | Low, Zhi Mei; ORCID: http://orcid.org/0000-0003-0848-4524 | PubMed URL: | 29205260 [http://www.ncbi.nlm.nih.gov/pubmed/?term=29205260] | ISSN: | 0004-8380 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/37357 | Type: | Article | Type of Clinical Study or Trial: | Case series or case report |
Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.